Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from KYORIN Pharmaceutical Co.,Ltd. ( (JP:4569) ) is now available.
KYORIN Pharmaceutical Co., Ltd. announced a resolution to distribute dividends from retained earnings, with a record date of March 31, 2025. Shareholders will receive a year-end dividend of ¥37.00 per share, which includes an ordinary dividend of ¥32.00 and a special dividend of ¥5.00, resulting in an annual dividend of ¥57.00 per share. This decision reflects the company’s strong financial performance and commitment to returning value to its shareholders.
More about KYORIN Pharmaceutical Co.,Ltd.
KYORIN Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of medical products. The company is known for producing a range of pharmaceutical products and has a significant market presence in Japan.
Average Trading Volume: 167,205
Technical Sentiment Signal: Sell
Current Market Cap: Yen84B
See more insights into 4569 stock on TipRanks’ Stock Analysis page.